{
    "ticker": "FBIO",
    "name": "Fortress Biotech, Inc.",
    "description": "Fortress Biotech, Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare diseases and unmet medical needs. Founded in 2016, Fortress operates by acquiring and developing a diverse portfolio of assets in various stages of clinical development. The company aims to leverage its proprietary platforms and scientific expertise to bring new treatments to market. Fortress's strategy includes both in-house development of its drug candidates and collaboration with other biotechnology firms to enhance its product pipeline. The company's lead product candidates address conditions such as cancer, dermatological diseases, and neurological disorders, highlighting its commitment to improving patient outcomes. Fortress is also dedicated to advancing the understanding of complex diseases through research and development, contributing to the broader scientific community. With a robust pipeline and a focus on innovation, Fortress Biotech is positioned to make a significant impact in the biopharmaceutical industry.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "New York, New York, USA",
    "founded": "2016",
    "website": "https://www.fortressbiotech.com",
    "ceo": "Lindsay A. Rosenwald",
    "social_media": {
        "twitter": "https://twitter.com/FortressBio",
        "linkedin": "https://www.linkedin.com/company/fortress-biotech"
    },
    "investor_relations": "https://www.fortressbiotech.com/investors",
    "key_executives": [
        {
            "name": "Lindsay A. Rosenwald",
            "position": "CEO"
        },
        {
            "name": "Dr. Michael A. R. T. F. Rosenfeld",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology",
            "products": [
                "FB-401",
                "FB-703"
            ]
        },
        {
            "category": "Dermatology",
            "products": [
                "FB-102"
            ]
        }
    ],
    "seo": {
        "meta_title": "Fortress Biotech, Inc. | Innovative Biopharmaceutical Solutions",
        "meta_description": "Explore Fortress Biotech, Inc., a biopharmaceutical company dedicated to developing innovative therapies for rare diseases and unmet medical needs.",
        "keywords": [
            "Fortress Biotech",
            "Biopharmaceuticals",
            "Oncology",
            "Rare Diseases",
            "Innovative Therapies"
        ]
    },
    "faq": [
        {
            "question": "What is Fortress Biotech known for?",
            "answer": "Fortress Biotech is known for developing innovative therapies for rare diseases and unmet medical needs."
        },
        {
            "question": "Who is the CEO of Fortress Biotech?",
            "answer": "Lindsay A. Rosenwald is the CEO of Fortress Biotech, Inc."
        },
        {
            "question": "Where is Fortress Biotech headquartered?",
            "answer": "Fortress Biotech is headquartered in New York, New York, USA."
        },
        {
            "question": "What are Fortress Biotech's main product categories?",
            "answer": "Fortress Biotech's main product categories include oncology and dermatology."
        },
        {
            "question": "When was Fortress Biotech founded?",
            "answer": "Fortress Biotech was founded in 2016."
        }
    ],
    "competitors": [
        "VRTX",
        "EDIT",
        "CRSP",
        "BMRN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "REGN",
        "BIIB"
    ]
}